Pedal To Metal: WuXi Drives Up Greater China Healthcare Ambitions
This article was originally published in PharmAsia News
Executive Summary
Stepping out of its core lab discovery, contract research and manufacturing services into genomics, e-commerce and clinical screening testing, WuXi PharmaTech is fast moving an aspiration to seize broader opportunities in the China healthcare market. But analysts wonder whether its bread-and-butter pharma and biologics customers are on board.